Tag: Dr Rajesh Gokhale

The centre–state collaboration, signed in New Delhi in the presence of senior government leaders, marks a pivotal step towards India’s $1 trillion bioeconomy

The initiative provides shared infrastructure for startups, SMEs, academia, and industry to test, scale, and commercialise technologies

Mehta Family School of Biosciences and Biomedical Engineering to train 1,500+ leaders in Health Informatics, Wearable Health Technologies, AI in Healthcare, and Molecular Biology etc

India's bio-economy has witnessed a remarkable 16-fold rise in 10 years of the past one decade, from $ 10 Billion in 2014 to an impressive $165.7 Billion in 2024, claimed the Minister

As part of the celebrations, CSIR-IMTECH signed several MOUs’ with pharma industries for usage of Biofoundry to aid rapid development of precision biotherapeutics and early scaling up of proof of concept of biomolecules

Industry presentations from Immuneel Therapeutics, Micro CRISPR, Laurus Labs Ltd., and INTAS Pharma showcased the industry's work in CGT

BRIC has been instrumental in bringing together scientists and researchers across the institutions

The facility exemplifies how technological advancements in bioplastics can lead to economic growth

The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.

The competition was launched formally on 1st March, 2024 by opening call for applications